Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:00:01.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:01.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study details and documents with an access-restricted view.
    Difference
    17%
    Check dated 2026-09-23T00:12:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The revision tag on the page updates to Revision: v3.7.0, replacing Revision: v3.6.6. This reflects an update to the page's revision history/backend rather than a change to the study information shown.
    Difference
    0.1%
    Check dated 2026-09-16T00:09:03.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6, signaling a new page revision. This is a minor maintenance update and does not reflect changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-01T19:09:23.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    An NIH funding reference for 2017 was added to the study's identifier section, reflecting the funding source associated with the trial. This is an administrative detail that does not alter the study design, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-08-25T16:44:12.000Z thumbnail image

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.